Zobrazeno 1 - 10
of 39
pro vyhledávání: '"István Bodrogi"'
Autor:
D. Timothy Bishop, Radka Lohynska, Robert Huddart, Douglas F. Easton, Ludmila Liubchenko, Katherine L. Nathanson, Michael R. Stratton, Barbara L. Weber, Kelly-Anne Phillips, Parry Guilford, Michael Friedlander, Hans Stoll, Stéphane Richard, Catherine Bonaïti-Pellié, T. Oliver, Wilma Ormiston, Katherine M. Tucker, Mark H. Greene, Joan Kramer, David Forman, Elizabeth A. Rapley, Lawrence H. Einhorn, Gedske Daugaard, Axel Heidenreich, Sergei Tjulandin, Walter P. Weber, Michael A.S. Jewett, David W. Hogg, Sophie D. Fosså, Peter Albers, Rachel Linger, Lajos Géczi, Lola Johnson, Darshna Dudakia, Mary L. McMaster, Ketil Heimdal, István Bodrogi, Victoria K. Cortessis, Edith Olah, Peter A. Daly, Gillian P. Crockford, Agnès Chompret, Sarah Hockley
Publikováno v:
Human Molecular Genetics
Human Molecular Genetics, 2006, 15 (3), pp.443-51. ⟨10.1093/hmg/ddi459⟩
Human Molecular Genetics, Oxford University Press (OUP), 2006, 15 (3), pp.443-51. ⟨10.1093/hmg/ddi459⟩
Human Molecular Genetics, 2006, 15 (3), pp.443-51. ⟨10.1093/hmg/ddi459⟩
Human Molecular Genetics, Oxford University Press (OUP), 2006, 15 (3), pp.443-51. ⟨10.1093/hmg/ddi459⟩
A family history of disease is a strong risk factor for testicular germ cell tumour (TGCT). In order to identify the location of putative TGCT susceptibility gene(s) we conducted a linkage search in 237 pedigrees with two or more cases of TGCT. One h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1669ed70edbf7d179085b8ddd1c8754
http://doc.rero.ch/record/292102/files/ddi459.pdf
http://doc.rero.ch/record/292102/files/ddi459.pdf
Autor:
Vanda Plótár, Sándor Manninger, Zsuzsanna Pápai, Zsófia Küronya, István Bodrogi, József Lövey
Publikováno v:
Magyar Onkológia. 53:263-266
Absztrakt A szerzők a hazai irodalomban elsőkent ismertetik rectum-adenocarcinomabol szarmazo metakron izolalt penismetastasis esetet. Beteguknel rectum-adenocarcinoma kurativ műtetjere kerult sor, mely utan 4 es fel evvel eszleltek a penisben met
Autor:
I. Skoneczna, Christine Theodore, K. Ven, M. G. Leahy, Sandrine Marreaud, J.M. Kerst, Laurence Collette, R.D.T. Oliver, István Bodrogi
Publikováno v:
Annals of Oncology. 19:1304-1307
Background The aim of this study is to determine efficacy and feasibility of the combination regimen irinotecan and cisplatin in patients with cisplatin advanced penile cancer. Patients and methods Patients with T3, T4, N1, N2, N3 or M1 cisplatin adv
Autor:
Robert Huddart, Johannes Classen, Roberto Salvioni, Rainer Souchon, Walter Albrecht, Xavier Garcia del Muro, Malcolm David Mason, Michael Bamberg, Johnathan Joffe, Jutta Scheiderbauer, Annette Dieing, Oscar Leiva Galvis, Niels E. Skakkebæk, Ronald de Wit, William G. Jones, Sophie D. Fosså, Kai Uwe Koehrmann, H. G. Derigs, Silke Gillessen, Martin Fenner, Sergei Tjulandin, C Clemm, Wolfgang Hoeltl, Padraig Warde, Aude Flechon, Luis Paz Ares, Pieter H.M. De Mulder, S. Kliesch, Nicola Nicolai, Thomas Powles, László Kisbenedek, Lothar Weissbach, Craig R. Nichols, Hans von der Maase, Michael Jewett, Jörg Pont, Markus A. Kuczyk, Volker Loy, Christian Wittekind, Peter Albers, Jose Ramon Germa-Lluch, Felix Sedlmayer, Giovanni Rosti, D. Ondruš, Pilar Laguna, Heinz Schmidberger, István Bodrogi, Gabriella Cohn-Cedermark, Eva Cavallin-Ståhl, Jörg Beyer, Tim Oliver, Arthur Gerl, Gedske Daugaard, Stefan Weinknecht, Tobias Pottek, Hans-Joachim Schmoll, Maike de Wit, Rolf Mueller, Maria De Santis, Michael Hartmann, Graham M. Mead, Oliver Rick, Jean Pierre Droz, Christian K. Kollmannsberger, Hans U. Schmelz, Karim Fizazi, Gosse O N Oosterhof, Lori Wood, Thomas Gauler, Aslam Sohaib, Susanne Krege, Ferran Algaba, Alan Horwich, Eva Winter, Stéphane Culine, Giorgio Pizzocaro, Olbjørn Klepp, Axel Heidenreich, Klaus Peter Dieckmann, Jörg T. Hartmann, Mark Schrader, Lajos Géczi, Carsten Bokemeyer
Publikováno v:
European Urology
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
European Urology, Elsevier, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 3, pp. 497-513
European Urology, 53, 478-496
European Urology, 53, 3, pp. 478-496
European Urology, 2008, 53 (3), pp.497-513. ⟨10.1016/j.eururo.2007.12.025⟩
European Urology, 53, 497-513
European Urology, 53(3), 478-496. Elsevier
European Urology, 53(3), 497-513. Elsevier
Objectives: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the
Autor:
Krisztián Nagyiványi, I. Gaudi, Lajos Géczi, László Noszek, István Bodrogi, Péter Prekopp, Krisztina Bíró
Publikováno v:
Oncology. 70:177-184
Objective: The characteristics and risk factors of the long-term ototoxic effect of cisplatin in testicular cancer patients was studied by measuring distortion product otoacoustic emissions (DPOAEs), which is a highly sensitive, new method for detect
Autor:
Virginie Durbecq, Marianne Paesmans, Fatima Cardoso, Christine Desmedt, Angelo Di Leo, Stephen Chan, Kay Friedrichs, Tamas Pinter, Simon Van Belle, Elizabeth Murray, István Bodrogi, Euan Walpole, Bernard Lesperance, Stefan Korec, John Crown, Peter Simmonds, Thimothy J. Perren, Jean-Yves Leroy, Ghizlane Rouas, Christos Sotiriou, Martine Piccart, Denis Larsimont
Publikováno v:
Molecular Cancer Therapeutics. 3:1207-1214
Purpose: The predictive value of topoisomerase-IIα (topo-II) has been evaluated in advanced breast cancer patients randomly treated with single-agent doxorubicin or docetaxel. Experimental design: Primary tumor samples from patients enrolled in a ra
Autor:
N. Nicolai, O. Leiva, Johnathan K Joffe, O. Klepp, P. Walz, Rolf Mueller, M. de Wit, S. Clemm, S. D. Fossa, Niels E. Skakkebæk, Gedske Daugaard, Robert Huddart, S. Tjulandin, M. Kuczyk, S. Krege, M. D. Mason, G. Kaiser, X. Garcia del Muro, László Kisbenedek, Gosse O N Oosterhof, O. Rick, Wolfgang Hoeltl, S. Kliesch, H. von der Maase, M. Bamberg, A. Gerl, N. Aass, Christian Kollmannsberger, G. Pizzocaro, M. Hartmann, L. Weissbach, O. Pont, U. Studer, P. Albers, M.P. Laguna, V. Loy, R. Souchon, H.-J. Schmoll, J. P. Droz, P.H.M. de Mulder, Heinz Schmidberger, Jörg Beyer, K. Fizazi, Tobias Pottek, J. Classen, G. M. Mead, Alan Horwich, L. Paz Ares, C. Bokemeyer, W. Jones, Eva Winter, T. Oliver, H. G. Derigs, J. R. Germa-Lluch, Felix Sedlmayer, István Bodrogi, Stefan Weinknecht, M. Flasshove, A. Heidenreich, F. Algaba, R. de Wit, S. Culine, K. U. Koehrmann, C. Wittekind, J. T. Hartmann, K. P. Dieckmann, W. Siegert, G. Rosti
Publikováno v:
Annals of Oncology, 15, 9, pp. 1377-99
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Annals of Oncology, 15, 1377-99
Annals of Oncology, 15, 1377-1399. Elsevier Ltd.
Schmoll, H J, Souchon, R, Krege, S, Albers, P, Beyer, J, Kollmannsberger, C, Fossa, S D, Skakkebaek, N E, de Wit, R, Fizazi, K, Droz, J P, Pizzocaro, G, Daugaard, G, de Mulder, P H, Horwich, A, Oliver, T, Huddart, R, Rosti, G, Paz Ares, L, Pont, O, Hartmann, J T, Aass, N, Algaba, F, Bamberg, M, Bodrogi, I, Bokemeyer, C, Classen, J, Clemm, S, Culine, S, de Wit, M, Derigs, H G, Dieckmann, K P, Flasshove, M, Garcia del Muro, X, Gerl, A, Germa-Lluch, J R, Hartmann, M, Heidenreich, A, Hoeltl, W, Joffe, J, Jones, W, Kaiser, G, Klepp, O, Kliesch, S, Kisbenedek, L, Koehrmann, K U, Kuczyk, M, Laguna, M P, Leiva, O, Loy, V, Mason, M D, Mead, G M, Mueller, R P, Nicolai, N, Oosterhof, G O, Pottek, T, Rick, O, Schmidberger, H, Sedlmayer, F, Siegert, W, Studer, U, Tjulandin, S, Maase, H V D, Walz, P, Weinknecht, S, Weissbach, L, Winter, E & Wittekind, C 2004, ' European consensus on diagnosis and treatment of germ cell cancer : A report of The European Germ Cell Cancer Consensus Group (EGCCCG) ', European Urology, vol. 15, pp. 1377-1399 .
Germ cell tumour is the most frequent malignant tumour type in young men with a 100% rise in the incidence every 20 years. Despite this, the high sensitivity of germ cell tumours to platinum-based chemotherapy, together with radiation and surgical me
Publikováno v:
Oncology. 60:228-234
Objective: To determine whether a testicular self-examination-based early-detection program may help in the early diagnosis of testicular cancer. Methods: Advertisements were placed in the media describing the early signs of testicular cancer, the ri
Autor:
E. Lallemand, L. Collette, Stan B. Kaye, C.J. van Groeningen, István Bodrogi, S. P. Stenning, L. de Prijck, Sophie D. Fosså, Graham M. Mead, Phm deMulder, R deWit, Richard Sylvester, Michael Cullen
Publikováno v:
Journal of Clinical Oncology, 16, 692-701
Journal of Clinical Oncology, 16, 2, pp. 692-701
Journal of Clinical Oncology, 16(2), 692-701. American Society of Clinical Oncology
Journal of Clinical Oncology, 16, 2, pp. 692-701
Journal of Clinical Oncology, 16(2), 692-701. American Society of Clinical Oncology
PURPOSE The aim of this randomized trial was to assess the potential therapeutic advantage of an intensive induction-sequential chemotherapy schedule (bleomycin, vincristine, cisplatin [BOP])/etoposide, ifosfamide, cisplatin, and bleomycin [VIP-B]),
Autor:
Anikó, Maráz, István, Bodrogi, András, Csejtei, Magdolna, Dank, Lajos, Géczi, Zsófia, Küronya, László, Mangel, Agota, Petrányi, Miklós, Szûcs, György, Bodoky
Publikováno v:
Magyar onkologia. 57(3)
Pazopanib, a tyrosine kinase inhibitor, is one of the new registered first-line therapeutic options in the treatment of metastatic clear cell renal carcinoma. Our aim was to evaluate the efficiency and toxicity of first-line pazopanib therapy adminis